Aphria Inc.
NASDAQ: APHA
$15.38
+$0.00 (+0.0%)
Closing price May 7, 2021
The coming elections may provide a huge tailwind for the cannabis industry in the United States. In a number of states, recreational marijuana will be on the ballot, which could be huge for three top...
1 year ago
Last Updated: 1 year ago
Lower-priced stocks offer not only a way to make some good money but to get a higher share count. The five are likely to survive the current troubles and could very well offer patient investors some...
1 year ago
Last Updated: 1 year ago
Marijuana stocks have suffered a terrible beating in the past year or so. Here's a look at six former high-flyers and their prospects for a recovery.
1 year ago
Last Updated: 1 year ago
Aphria, an analyst favorite among pot stocks, rallies after market selloff Thursday.
1 year ago
Cannabis stocks in general stumbled in the latter half of last year. Wall Street expects profits, and none of these companies is anywhere near profitability. In the United States, high state and...
1 year ago
Aurora Cannabis closed its acquisition of Reliva ahead of schedule but poor results from Canopy Growth may have dinged pot stocks.
1 year ago
Last Updated: 1 year ago
Beginning June 8, Canadian marijuana company Aphria will switch from the NYSE to the Nasdaq exchange, with the same symbol.
1 year ago
Last Updated: 1 year ago
The May 15 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks decreased, and in one stock incredibly.
1 year ago
Aphria stays strong while Green Growth, which tried to buy it, goes bust. Canadian rival Aurora buys U.S. hemp retailer Reliva.
1 year ago
Canadian pot company Aphria is well positioned in the medical and recreational sectors. It has eyes on Europe but the coronavirus has stalled legalization efforts in the U.S.
1 year ago
The April 30 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
1 year ago
Here's a look at what has caused Canada's marijuana sales to increase so slowly, what impact that had on Aphria in particular, and how the pandemic will affect that company's future.
1 year ago
The April 15 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
1 year ago
In pandemic times, solid balance sheets have been a beacon of hope to investors, and for those wishing to get into the cannabis industry, a cash-rich company like Aphria may be that vehicle.
1 year ago
The entire Canadian pot industry is in wait-and-see mode due to the pandemic, both the companies and investors. However, it will not remain that way forever. Is Aphria growing stronger as the...
1 year ago